SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001104659-24-012944
Filing Date
2024-02-09
Accepted
2024-02-09 16:10:16
Documents
1
Group Members
ALPHABET HOLDINGS LLCALPHABET INC.GV 2016 GP, L.L.C.GV 2016 GP, L.P.XXVI HOLDINGS INC.

Document Format Files

Seq Description Document Type Size
1 SC 13G/A tm244701-4_sc13ga.htm SC 13G/A 151238
  Complete submission text file 0001104659-24-012944.txt   153093
Mailing Address 300 TECHNOLOGY SQUARE 8TH FLOOR CAMBRIDGE MA 02139
Business Address 300 TECHNOLOGY SQUARE 8TH FLOOR CAMBRIDGE MA 02139 857-201-2700
Dianthus Therapeutics, Inc. /DE/ (Subject) CIK: 0001690585 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-90538 | Film No.: 24614943
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 1600 AMPHITHEATRE PARKWAY MOUNTAIN VIEW CA 94043
Business Address 1600 AMPHITHEATRE PARKWAY MOUNTAIN VIEW CA 94043 650-335-5278
GV 2016, L.P. (Filed by) CIK: 0001721789 (see all company filings)

IRS No.: 611775632 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A